{"id":"W4386688264","doi":"10.51731/cjht.2023.734","title":"Trastuzumab Deruxtecan (Enhertu)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Trastuzumab; Medicine; Reimbursement; Metastatic breast cancer; Oncology; Chemotherapy; Breast cancer; Internal medicine; Disease; Adjuvant; Cancer; Intensive care medicine; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007256189,0.0002097523,0.0002192382,0.0007593105,0.0001985898,0.0006837919,0.0003525598,0.0003697271,0.01446904],"category_scores_gemma":[0.001067204,0.00006995764,0.0002935094,0.0005208009,0.0002532889,0.0003508745,0.0002666029,0.0004580703,0.002096809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00279506,"about_ca_system_score_gemma":0.002840029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03482638,"about_ca_topic_score_gemma":0.1113996,"domain_scores_codex":[0.9996227,0.00007800184,0.00002975646,0.0000355944,0.0001912302,0.0000425755],"domain_scores_gemma":[0.9996043,0.00007998831,0.00007232664,0.00001199678,0.0001825116,0.00004887093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000357525,0.00003759881,0.0008889298,0.002055902,0.00007427438,0.0001252938,0.00003231553,0.0001920481,0.002381189,0.005086292,0.1462943,0.8424743],"study_design_scores_gemma":[0.0001273094,0.0001879672,0.003439944,0.001035795,0.00006683508,0.0002918772,0.00002266268,0.0001000506,0.002405575,0.0003554402,0.9919577,0.000008904403],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.01407006,0.6092663,0.001672964,0.01449174,0.002306783,0.0003387938,0.004393535,0.0003163357,0.3531434],"genre_scores_gemma":[0.1854613,0.4852616,0.005414978,0.01526414,0.001030631,0.000235759,0.006763228,0.00006955956,0.3004988],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03482638,"threshold_uncertainty_score":0.06924731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1028653130584693,"score_gpt":0.398326580389078,"score_spread":0.2954612673306086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}